「fo」の検索結果
125件：36～40件目を表示
-
CEO Message | About Senju | SENJU Pharmaceutical
Since Senju was established in 1947, we have been making efforts for more than 70 years to develop excellent medicines and services focusing on the ophthalmology field through our unique ideas and R&a...
http://www.senju.co.jp/english/about/message.html -
Meetings of the Minds | Research & Development | SENJU Pharmaceutica
non-clinical ocular instillation toxicity studies of SJP-0132, a TRPV1 antagonist, a novel eye drop for dry eye disease Hideya Yonekura, Kotaro Yamada, Gen Suzuki, Yu Haranosono, Yoshinori Yamagiwa, I...
http://www.senju.co.jp/english/rd/society/ -
Presence of Products | Overseas Activities | SENJU Pharmaceutical
d in JP About Senju Lists About Senju CEO Message Management Policy Company Profile Our Initiatives for Society / Environment Business Activities Research Laboratories Production
http://www.senju.co.jp/english/global/world.html -
Medical devices and healthcare | Business Activities | About Senju | SENJU Pharmaceutical
ements in the new era through medical devices. Today, in the era of the 100-year-life, digital transformation is being promoted in various fields.Senju Pharmaceutical Co., Ltd. will start the medical ...
https://www.senju.co.jp/english/about/business/device.html -
8752506013.indd
眼科用補体第 5 成分阻害薬／ポリエチレングリコール共役 RNA アプタマー アバシンカプタド ペゴルナトリウム 硝子体内注射液 劇薬、処方箋医薬品 注意－医師等の処方箋により 使用すること for intravitreal injection 20mg/mL 日本標準商品分類番号 8 7 1 3 1 9 貯法： 2 ～ 8 ℃で保存 有効期間：36箇月 条件付き承認品目 2025年11月...
https://www.senju.co.jp/system/files/product_other_file/2025-11/izervay_202509__IZV31601Z31_2.pdf